The molecular effect of ZD6474, a dual tyrosine kinase inhibitor of epidermal growth factor receptor and vascular endothelial growth factor receptor on breast cancer progression and treatment
JavaScript is disabled for your browser. Some features of this site may not work without it.
The molecular effect of ZD6474, a dual tyrosine kinase inhibitor of epidermal growth factor receptor and vascular endothelial growth factor receptor on breast cancer progression and treatment